Relay Therapeutics
RLAY
#4554
Rank
โ‚ฌ1.98 B
Marketcap
10,37ย โ‚ฌ
Share price
-0.82%
Change (1 day)
296.13%
Change (1 year)

Revenue for Relay Therapeutics (RLAY)

Revenue in 2025 (TTM): โ‚ฌ13.63 Million

According to Relay Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.16 Million. an increase over the revenue in the year 2024 that were of โ‚ฌ9.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Relay Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ13.07 M35.93%
2024 โ‚ฌ9.61 M-58.39%
2023 โ‚ฌ23.1 M1694.95%
2022 โ‚ฌ1.28 M-51.86%
2021 โ‚ฌ2.67 M-96.02%
2020 โ‚ฌ67.19 M
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA